Eli Lilly

Eli Lilly and Company, founded in 1876, is a global leader in pharmaceuticals and biotechnology. Headquartered in Indianapolis, Indiana, the company has established itself as a key player in the drug development industry, with a strong focus on innovation and research. The company is dedicated to improving patient outcomes through cutting-edge treatments and comprehensive healthcare solutions.

Under the leadership of CEO David A. Ricks, Eli Lilly continues to push the boundaries of science, particularly in the fields of diabetes care, oncology, and immunology. The company’s robust pipeline of products and its commitment to addressing unmet medical needs have positioned it at the forefront of medical advancements. With a workforce of approximately 45,000 employees, Eli Lilly is driven by a mission to make life better for people around the world.

Eli Lilly's extensive portfolio includes treatments for pain management, endocrinology, and other critical therapeutic areas. The company leverages its expertise in biotechnology to develop innovative solutions that enhance the quality of life for patients. By investing in research and development, Eli Lilly continues to deliver groundbreaking therapies that set new standards in healthcare.